All Stories

  1. The Mediterranean Diet and Cardiovascular Protection: Biochemical Mechanisms with Emphasis on Platelet-Activating Factor
  2. Validation of the food compass score through 24 h recalls and measurement of erythrocyte fatty acids in a mediterranean population
  3. Association of apolipoprotein B, excess apolipoprotein B and apoB/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002–2022)
  4. Immune-related biochemical markers and 20-year incidence of atherosclerotic cardiovascular disease: the ATTICA study (2002–2022)
  5. Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)
  6. Platelet-Activating Factor-Induced Inflammation in Obesity: A Two-Sided Coin of Protection and Risk
  7. Revisiting the Role of Platelet-Activating Factor in COVID-19-Induced Cardiovascular Complications
  8. Gilthead seabream (Sparus aurata) fed with polar lipids from olive oil industry by-products: Shelf-life, microbiological and physicochemical characteristics during storage at 2 °C
  9. Effect of moderate wine consumption on the activity of enzymes involved in platelet-activating factor metabolism and thrombotic biomarkers: a randomised, single-blind, parallel, clinical study in CHD men patients
  10. Winery By-Products In Vitro and In Vivo Effects on Atherothrombotic Markers: Focus on Platelet-Activating Factor
  11. Consumption of a Mediterranean lean fish enriched with platelet-activating factor inhibitors extracted from olive pomace favorably modulates hemostasis and thrombosis in healthy adults with overweight
  12. Deciphering the associations of selenium distribution in serum GPx-3 and selenoprotein P with cardiovascular risk factors in a healthy population with moderate levels of selenium: The ATTICA study
  13. Is Platelet-Activating Factor the Missing Link Between COVID-19 and Atherosclerosis?
  14. Exploring the Effect of Resveratrol, Tyrosol, and Their Derivatives on Platelet-Activating Factor Biosynthesis in U937 Cells
  15. The Impact of Dietary Carbohydrates on Inflammation-Related Cardiovascular Disease Risk: The ATTICA Study (2002–2022)
  16. Resveratrol, Tyrosol and Their Derivatives Inhibit Platelet Activating Factor Biosynthetic Enzymes in Homogenized U-937 Cells
  17. Effect of Spirulina Nigrita® Supplementation on Indices of Exercise-Induced Muscle Damage after Eccentric Protocol of Upper Limbs in Apparently Healthy Volunteers
  18. Does Yogurt Enriched with Platelet-Activating Factor Inhibitors from Olive Oil By-Products Affect Gut Microbiota and Faecal Metabolites in Healthy Overweight Subjects? (A randomized, parallel, three arm trial.)
  19. Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)
  20. Associations of phase angle with platelet-activating factor metabolism and related dietary factors in healthy volunteers
  21. Food Compass Score predicts incident cardiovascular disease: The ATTICA cohort study (2002–2022)
  22. Selenium, Selenoproteins and 10-year Cardiovascular Risk: Results from the ATTICA Study
  23. Food Compass Score and its association with inflammatory markers and homocysteine in cardiovascular disease-free adults: a cross-sectional analysis of the ATTICA epidemiological study
  24. The Involvement of Lipid Mediators in the Mechanisms of Exercise-Induced Muscle Damage
  25. Protective Effect of Olive Oil Microconstituents in Atherosclerosis: Emphasis on PAF Implicated Atherosclerosis Theory
  26. Platelet activating factor: Have we been missing the forest for the trees?
  27. Is there an interplay between the SARS‐CoV ‐2 spike protein and Platelet‐Activating factor?
  28. Consumption of Farmed Fish, Fed with an Olive-Pomace Enriched Diet, and Its Effect on the Inflammatory, Redox, and Platelet-Activating Factor Enzyme Profile of Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial
  29. Consumption of yogurt enriched with polar lipids from olive oil by-products reduces platelet sensitivity against platelet activating factor and inflammatory indices: A randomized, double-blind clinical trial
  30. Sensory evaluation and consumer response of fillets from seabream fed with lipids extracted from olive oil by-products
  31. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers
  32. The effect of moderate wine consumption on cytokine secretion by peripheral blood mononuclear cells: A randomized clinical study in coronary heart disease patients
  33. Antithrombotic properties of differently fed farmed gilthead sea bream: In vitro and in vivo studies
  34. Activities of platelet-activating factor (PAF) enzymes after daily consumption for two months of a yogurt enriched with natural origin PAF inhibitors
  35. Consumption of Enriched Yogurt with PAF Inhibitors from Olive Pomace Affects the Major Enzymes of PAF Metabolism: A Randomized, Double Blind, Three Arm Trial
  36. Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study
  37. Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
  38. Effect of Differently Fed Farmed Gilthead Sea Bream Consumption on Platelet Aggregation and Circulating Haemostatic Markers among Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial
  39. Can Exercise-Induced Muscle Damage Be a Good Model for the Investigation of the Anti-Inflammatory Properties of Diet in Humans?
  40. Associations between red blood cells fatty acids, desaturases indices and metabolism of platelet activating factor in healthy volunteers
  41. COVID‐19, microthromboses, inflammation, and platelet activating factor
  42. The French paradox three decades later: Role of inflammation and thrombosis
  43. Coronavirus 2019, Microthromboses, and Platelet Activating Factor
  44. Changes of rate of torque development in soccer players after a Loughborough Intermittent Shuttle Test: Effect of bovine colostrum supplementation
  45. Cardioprotective properties of a novel enriched yogurt with inhibitors of Platelet Activating Factor (PAF)
  46. Mediterranean diet and the postprandial state: A focus on inflammation, endothelial dysfunction, and hemostasis
  47. Cardioprotective properties of fish enriched with bioactive lipids from olive oil by products
  48. Anti-platelet and anti-inflammatory properties of an ethanol-water red grape pomace extract
  49. Gut microbiome characteristics at the crossroads of metabolic health and lifestyle patterns in an adult population
  50. Mining possible associations of faecal A. muciniphila colonisation patterns with host adiposity and cardiometabolic markers in an adult population
  51. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein‐Associated Phospholipase A2Activity: A Cross‐Sectional Study
  52. Effects of nut and seed consumption on markers of glucose metabolism in adults with prediabetes: a systematic review of randomised controlled trials
  53. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial
  54. Yogurt enriched with a natural extract rich in PAF inhibitors and polyphenols. Study design and rationale of a randomized, double blinded, placebo-controlled, parallel intervention study
  55. Evaluation of anti-platelet activity of grape pomace extracts
  56. Mediterranean diet and platelet-activating factor; a systematic review
  57. Suppression of DNA/RNA and protein oxidation by dietary supplement which contains plant extracts and vitamins: a randomized, double-blind, placebo-controlled trial
  58. Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study
  59. Wine and its metabolic effects. A comprehensive review of clinical trials
  60. Fish consumption and cardiovascular disease related biomarkers: A review of clinical trials
  61. Amino acid profile and metabolic syndrome in a male Mediterranean population: A cross-sectional study
  62. Adherence to the Mediterranean diet is associated with the gut microbiota pattern and gastrointestinal characteristics in an adult population
  63. Influence of Genes on the Lifespan of Long- and Short-Lived Families
  64. Postprandial effects of wine consumption on Platelet Activating Factor metabolic enzymes
  65. Anti-platelet effects of anti-glaucomatous eye drops: an in vitro study on human platelets
  66. A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players
  67. Ιn Vivo Effects of Tenofovir-DF/Emtricitabine and Abacavir/Lamivudine with Atazanavir-R on Platelet Activating Factor Metabolism in HIV Naive Patients
  68. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study
  69. Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men
  70. Hierarchical modelling of blood lipids’ profile and 10-year (2002–2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study
  71. Cave Cyanobacteria showing antibacterial activity
  72. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions
  73. In vitro assessment of antioxidant activity of tyrosol, resveratrol and their acetylated derivatives
  74. Mediterranean Diet and the Postprandial State
  75. Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells
  76. Gender-specific distribution of selenium to serum selenoproteins: Associations with total selenium levels, age, smoking, body mass index, and physical activity
  77. In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients
  78. The relation of diet with PAF and its metabolic enzymes in healthy volunteers
  79. Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymes
  80. Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy
  81. Additional benefit in CVD risk indices derived from the consumption of fortified milk when combined with a lifestyle intervention
  82. Baseline and 6-Week Follow-Up Levels of PAF and Activity of Its Metabolic Enzymes in Patients With Heart Failure and Healthy Volunteers—A Pilot Study
  83. Effects of HAART on Platelet-Activating Factor Metabolism in Naive HIV-Infected Patients I: Study of the Tenofovir-DF/Emtricitabine/Efavirenz HAART Regimen
  84. Mediterranean wild plants reduce postprandial platelet aggregation in patients with metabolic syndrome
  85. Effects of Highly Active Antiretroviral Therapy on Platelet Activating Factor Metabolism in Naïve HIV-Infected Patients: II) Study of the Abacavir/Lamivudine/Efavirenz Haart Regimen
  86. Mineral Intake
  87. PAF and its metabolic enzymes in healthy volunteers: Interrelations and correlations with basic characteristics
  88. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with OxLDL and IL-1β effects
  89. Platelet-Activating Factor and Its Basic Metabolic Enzymes in Blood of Naive HIV-Infected Patients
  90. Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration
  91. High-throughput quantification of selenium in individual serum proteins from a healthy human population using HPLC on-line with isotope dilution inductively coupled plasma-MS
  92. In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism
  93. Acute resistance exercise attenuates fasting and postprandial triglyceridemia in women by reducing triglyceride concentrations in triglyceride-rich lipoproteins
  94. Antioxidant and anti-inflammatory activity of red and white wine extracts
  95. Dietary habits of Greek adults and serum total selenium concentration: the ATTICA study
  96. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: the ATTICA study
  97. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women
  98. Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: the ATTICA study
  99. N-Terminal ProBNP Distribution and Correlations With Biological Characteristics in Apparently Healthy Greek Population: ATTICA Study
  100. Oral supplementation with l-aspartate and l-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit
  101. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
  102. Antioxidant and lipoxygenase inhibitory activities of pumpkin seed extracts
  103. Lipid minor constituents in wines. A biochemical approach in the French paradox
  104. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure
  105. Serum Total Selenium Status in Greek Adults and Its Relation to Age. The ATTICA Study Cohort
  106. Anti-Platelet-Activating Factor Effects of Highly Active Antiretroviral Therapy (HAART): A New Insight in the Drug Therapy of HIV Infection?
  107. BIOACTIVE POLAR LIPIDS IN OLIVE OIL, POMACE AND WASTE BYPRODUCTS
  108. Chemical Composition of Greek Avgotaracho Prepared from Mullet (Mugil cephalus): Nutritional and Health Benefits
  109. Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB x NZW F1 hybrid mice
  110. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study
  111. Development, reliability and validity of a new motorized isometric dynamometer for measuring strength characteristics of elbow flexor muscles
  112. Boiled wild artichoke reduces postprandial glycemic and insulinemic responses in normal subjects but has no effect on metabolic syndrome patients
  113. Food Ingredients and Lipid Mediators
  114. Effect of Fast-Food Mediterranean-Type Diet on Human Plasma Oxidation
  115. IL-1β induces a rapid and transient increase of intracellular platelet activating factor in a human mesangial cell line—Modulation by an olive oil polar lipid extract
  116. Antithrombotic and Antiatherosclerotic Properties of Olive Oil and Olive Pomace Polar Extracts in Rabbits
  117. Biological Activity of Acetylated Phenolic Compounds
  118. Characterization of the De Novo Biosynthetic Enzyme of Platelet Activating Factor, DDT-Insensitive Cholinephosphotransferase, of Human Mesangial Cells
  119. Isolation and identification of hydroxyl–platelet-activating factor from natural sources
  120. Effect of Traditional Greek Mediterranean Meals on Platelet Aggregation in Normal Subjects and in Patients with Type 2 Diabetes Mellitus
  121. Platelet-activating factor (PAF) increase intracellular lipid accumulation by increasing both LDL and scavenger receptors in human mesangial cells
  122. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects’ platelet aggregation
  123. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits
  124. Effects of baseline serum levels of Se on markers of eccentric exercise-induced muscle injury
  125. Synthesis and biological evaluation of novel steroid-modified ether phospholipids
  126. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria)
  127. Understanding local Mediterranean diets: A multidisciplinary pharmacological and ethnobotanical approach
  128. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers
  129. Characterization of bioactive glycolipids from Scytonema julianum (cyanobacteria)
  130. Platelet activating factor— a molecular link between atherosclerosis theories
  131. Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties
  132. Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients
  133. Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria)
  134. Oleuropein Inhibits LDL Oxidation Induced by Cooking Oil Frying By-products and Platelet Aggregation Induced by Platelet-Activating Factor
  135. SEPARATION OF POLAR LIPIDS FROM SOYBEAN OIL AND COTTON SEED OIL BY ONE-STEP HPLC SYSTEM. BIOLOGICAL ACTIVITY OF ISOLATED LIPIDS
  136. Biologically Active Lipids with Antiatherogenic Properties from White Wine and Must
  137. Antithrombotic Lipid Minor Constituents from Vegetable Oils. Comparison between Olive Oils and Others
  138. Is Platelet-Activating Factor Produced during Hemodialysis with AN-69 Polyacrylonitrile Membrane?
  139. Separation of Biologically Active Lipids from Red Wine
  140. Biologically active lipids from olive oil with antiatherogenetic action
  141. DETERMINATION OF PLATELET-ACTIVATING FACTOR BY HPLC WITH FLUORESCENCE DETECTION
  142. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid
  143. Synthesis of a new phosphoglycolipid with biological activity towards platelets
  144. Identification and Study of Gangliosides from Scomber scombrus Muscle
  145. Separation of Several Main Glycolipids into Classes and Partially into Species by HPLC and UV-Detection
  146. Isolation and Complete Separation of Lipids From Natural Sources
  147. Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor
  148. Platelet-Activating Factor (PAF) Antagonists in Foods:  A Study of Lipids with PAF or Anti-PAF-like Activity in Cow's Milk and Yogurt
  149. Platelet-Activating Factor Levels and PAF Acetylhydrolase Activities in Patients with Primary Glomerulonephritis
  150. Implication of PAF and Acetylhydrolase (PAF-AH) Activity in Periodontal Disease
  151. Biologically Active Lipids from S. Scombrus
  152. A Discovery Trip to Compounds with PAF-Like Activity
  153. Lipid Separation from Urtica dioica:  Existence of Platelet-Activating Factor
  154. The Production of Platelet-Activating Factor (PAF) during Hemodialysis with Cuprophane Membrane. Does the Calcium Concentration in the Dialysate Play Any Role on It?
  155. Platelet-activating factor acetylhydrolase (PAF-AH) in human kidney
  156. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated
  157. A simple and precise method for the routine determination of platelet-activating factor in blood and urine
  158. Separation of the Main Neutral Lipids into Classes and Species by PR-HPLC and UV Detection